367 related articles for article (PubMed ID: 18003666)
41. [Hiperhomocysteinemia in active and passive smokers and the levels of folate and vitamin B6 in plasma].
Marszałł ML; Makarowski R; Hinc S; Kłos M; Czarnowski W
Przegl Lek; 2008; 65(10):486-90. PubMed ID: 19189529
[TBL] [Abstract][Full Text] [Related]
42. Homocysteine-reducing strategies improve symptoms in chronic schizophrenic patients with hyperhomocysteinemia.
Levine J; Stahl Z; Sela BA; Ruderman V; Shumaico O; Babushkin I; Osher Y; Bersudsky Y; Belmaker RH
Biol Psychiatry; 2006 Aug; 60(3):265-9. PubMed ID: 16412989
[TBL] [Abstract][Full Text] [Related]
43. Effect of fortified spread on homocysteine concentration in apparently healthy volunteers.
van Vliet T; Jacobs RG; de Deckere E; van den Berg H; de Bree A; van der Put NM
Eur J Clin Nutr; 2007 Jun; 61(6):769-78. PubMed ID: 17151589
[TBL] [Abstract][Full Text] [Related]
44. Vitamins and minerals 4: overview of folate and the B vitamins.
Thompson J
Community Pract; 2006 Jun; 79(6):197-8. PubMed ID: 16780289
[TBL] [Abstract][Full Text] [Related]
45. Effect of folate, vitamin B6, and vitamin B12 intake and MTHFR C677T polymorphism on homocysteine concentrations of renal transplant recipients.
Biselli PM; Sanches de Alvarenga MP; Abbud-Filho M; Ferreira-Baptista MA; Galbiatti AL; Goto MT; Cardoso MA; Eberlin MN; Haddad R; Goloni-Bertollo EM; Pavarino-Bertelli EC
Transplant Proc; 2007 Dec; 39(10):3163-5. PubMed ID: 18089344
[TBL] [Abstract][Full Text] [Related]
46. Interventions for lowering plasma homocysteine levels in dialysis patients.
Nigwekar SU; Kang A; Zoungas S; Cass A; Gallagher MP; Kulshrestha S; Navaneethan SD; Perkovic V; Strippoli GF; Jardine MJ
Cochrane Database Syst Rev; 2016 May; 2016(5):CD004683. PubMed ID: 27243372
[TBL] [Abstract][Full Text] [Related]
47. The effects of vitamin supplementation and MTHFR (C677T) genotype on homocysteine-lowering and migraine disability.
Lea R; Colson N; Quinlan S; Macmillan J; Griffiths L
Pharmacogenet Genomics; 2009 Jun; 19(6):422-8. PubMed ID: 19384265
[TBL] [Abstract][Full Text] [Related]
48. Effect of homocysteine-lowering therapy with folic acid, vitamin B12, and vitamin B6 on clinical outcome after percutaneous coronary intervention: the Swiss Heart study: a randomized controlled trial.
Schnyder G; Roffi M; Flammer Y; Pin R; Hess OM
JAMA; 2002 Aug; 288(8):973-9. PubMed ID: 12190367
[TBL] [Abstract][Full Text] [Related]
49. Randomized placebo-controlled trial assessing a treatment strategy consisting of pravastatin, vitamin E, and homocysteine lowering on plasma asymmetric dimethylarginine concentration in mild to moderate CKD.
Nanayakkara PW; Kiefte-de Jong JC; ter Wee PM; Stehouwer CD; van Ittersum FJ; Olthof MR; Teerlink T; Twisk JW; van Guldener C; Smulders YM
Am J Kidney Dis; 2009 Jan; 53(1):41-50. PubMed ID: 18786751
[TBL] [Abstract][Full Text] [Related]
50. Fortified mineral water improves folate status and decreases plasma homocysteine concentration in pregnant women.
Järvenpää J; Schwab U; Lappalainen T; Päkkilä M; Niskanen L; Punnonen K; Ryynänen M
J Perinat Med; 2007; 35(2):108-14. PubMed ID: 17302515
[TBL] [Abstract][Full Text] [Related]
51. Why is homocysteine elevated in renal failure and what can be expected from homocysteine-lowering?
van Guldener C
Nephrol Dial Transplant; 2006 May; 21(5):1161-6. PubMed ID: 16490741
[No Abstract] [Full Text] [Related]
52. Elevated homocysteine levels in patients with end-stage renal disease.
Nair AP; Nemirovsky D; Kim M; Geer EB; Farkouh ME; Winston J; Halperin JL; Robbins MJ
Mt Sinai J Med; 2005 Nov; 72(6):365-73. PubMed ID: 16358160
[TBL] [Abstract][Full Text] [Related]
53. [Meta-analysis on effect of combined supplementation of folic acid, vitamin B12 and B6 on risk of cardio-cerebrovascular diseases in randomized control trials].
Lan X; Dang SN; Zhao YL; Yan H; Yan H
Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Jul; 37(7):1028-34. PubMed ID: 27453118
[TBL] [Abstract][Full Text] [Related]
54. Homocysteine-lowering therapy and stroke risk, severity, and disability: additional findings from the HOPE 2 trial.
Saposnik G; Ray JG; Sheridan P; McQueen M; Lonn E;
Stroke; 2009 Apr; 40(4):1365-72. PubMed ID: 19228852
[TBL] [Abstract][Full Text] [Related]
55. Effect of Combination Folic Acid, Vitamin B
Stone KL; Lui LY; Christen WG; Troen AM; Bauer DC; Kado D; Schambach C; Cummings SR; Manson JE
J Bone Miner Res; 2017 Dec; 32(12):2331-2338. PubMed ID: 29244251
[TBL] [Abstract][Full Text] [Related]
56. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
[TBL] [Abstract][Full Text] [Related]
57. Randomized trial of FX high flux vs standard high flux dialysis for homocysteine clearance.
Mudge DW; Rogers R; Hollett P; Law B; Reiger K; Petrie JJ; Price L; Johnson DW; Campbell SB; Isbel NM; Sullivan M; Hawley CM
Nephrol Dial Transplant; 2005 Oct; 20(10):2178-85. PubMed ID: 16030045
[TBL] [Abstract][Full Text] [Related]
58. Effect of folic acid on endothelial function following acute myocardial infarction.
Moens AL; Claeys MJ; Wuyts FL; Goovaerts I; Van Hertbruggen E; Wendelen LC; Van Hoof VO; Vrints CJ
Am J Cardiol; 2007 Feb; 99(4):476-81. PubMed ID: 17293188
[TBL] [Abstract][Full Text] [Related]
59. A randomized placebo controlled trial of homocysteine lowering to reduce cognitive decline in older demented people.
Kwok T; Lee J; Law CB; Pan PC; Yung CY; Choi KC; Lam LC
Clin Nutr; 2011 Jun; 30(3):297-302. PubMed ID: 21216507
[TBL] [Abstract][Full Text] [Related]
60. Folic acid therapy reduces plasma homocysteine levels and improves plasma antioxidant capacity in hemodialysis patients.
Alvares Delfino VD; de Andrade Vianna AC; Mocelin AJ; Barbosa DS; Mise RA; Matsuo T
Nutrition; 2007 Mar; 23(3):242-7. PubMed ID: 17321110
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
